Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): Multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
- J. J. Hofstra
- , I. Kleine Budde
- , E. van Twuyver
- , G. Choi
- , M. Levi
- , F. W.G. Leebeek
- , J. G.R. de Monchy
- , P. F. Ypma
- , R. J. Keizer
- , A. D.R. Huitema
- , P. F.W. Strengers
Research output: Contribution to journal › Article › peer-review
23
Citations
(Scopus)